Description
GLOW Blend combines three of the most-studied peptides in skin and tissue-repair research in a single 70 mg vial: GHK-Cu, BPC-157 and TB-500. One vial and one preparation step replace three. Pure Peptides Canada supplies it with independent Janoshik testing, CAD pricing and tracked shipping from inside Canada.
GLOW Blend at a glance
- What it is: a lyophilized three-peptide blend of GHK-Cu, BPC-157 and TB-500 (thymosin beta-4), 70 mg per vial.
- Why researchers use it: to study a copper peptide focused on skin and matrix alongside the two most-cited repair peptides, at a fixed ratio.
- GLOW vs KLOW: KLOW is GLOW plus KPV, an anti-inflammatory tripeptide. Choose GLOW when you do not want the inflammation component.
- Supplied as: sealed lyophilized powder, 70 mg, single vial or box of 10.
- Delivery: ships from inside Canada by tracked Xpresspost in 3–7 days ($25 CAD), or free in 4–12 days on orders over $299.
What’s inside GLOW
| Component | What it is | Main research focus |
|---|---|---|
| GHK-Cu | Copper(II) complex of the tripeptide Gly-His-Lys | Collagen, elastin and matrix synthesis in skin cells |
| BPC-157 | 15-residue fragment of a gastric-juice protein | Tendon, gut and angiogenesis models |
| TB-500 | Synthetic thymosin beta-4, an actin-binding protein | Cell migration, skin and corneal wound models |
Why researchers study these three together
GHK-Cu has a long history in dermal research, where cell studies link it to collagen and glycosaminoglycan production in fibroblasts. BPC-157 and thymosin beta-4 dominate tissue-repair research, but through different mechanisms: BPC-157 is associated with angiogenesis and nitric-oxide signalling, thymosin beta-4 with cell migration through actin. Putting all three in one vial lets a lab study skin and repair models with a fixed ratio across every replicate.
The components each have their own preclinical literature, but this three-way combination has not been tested in controlled human trials. It is a research formulation, not a cosmetic or a medicine.
Regulatory status: none of the three components is an authorized drug in Canada. All three are named in Health Canada’s April 2026 advisory on unauthorized injectable peptides, and BPC-157 and TB-500 are on the World Anti-Doping Agency prohibited list. We sell GLOW strictly as a laboratory reagent for in-vitro research.
Why researchers order GLOW from Pure Peptides Canada
Add a 70 mg vial or a box of 10 above. Orders over $299 ship free across Canada.
See lab resultsGLOW Blend FAQ
Where can I buy GLOW Blend in Canada?
Pure Peptides Canada stocks GLOW as a 70 mg lyophilized research reagent and ships it from inside Canada by tracked Xpresspost in 3–7 days ($25 CAD), or free in 4–12 days on orders over $299.
What is in GLOW?
Three peptides: GHK-Cu, BPC-157 and TB-500 (thymosin beta-4), 70 mg in total per vial.
What is the difference between GLOW and KLOW?
KLOW contains the same three peptides plus KPV, the alpha-MSH tripeptide studied for anti-inflammatory signalling. Our KLOW guide compares the two.
Is GLOW third-party tested?
Yes. Janoshik Analytical, an independent lab, tests by HPLC for purity and mass spectrometry for identity. For a blend, check that the report identifies each component. Our COA guide explains how.
Is GLOW a skincare product?
No. Despite the name, GLOW is a laboratory research reagent, not a cosmetic. It is not for application to skin or any other human or animal use.
Can GLOW be used in people or animals?
No. It is for in-vitro laboratory research only and is not a drug, supplement, cosmetic or food. We do not provide dosing or administration information.
For laboratory research use only. Not a drug, supplement, food or cosmetic, not for human or veterinary use, and not intended to diagnose, treat, cure or prevent any disease.
Oliver Johnson –
For the price, you really can’t go wrong. took a little longer to get up to me but to be expected with canada post.
Johnathan Rato –
Excellent blend, easier than taking each one individually (less poking). Very happy with it